Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 9 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
3 authors at 1 institution in 1 country.
Kevin T BaumgartnerKevin T. Baumgartner, MD, is a senior resident in emergency medicine and will begin a fellowship in medical toxicology in July 2019. Steven J. Fishburn, MD, MSCR, is a fellow in medical toxicology and a specialist in occupational medicine. Michael E. Mullins MD, FACEP, FAACT, is an associate professor in emergency medicine at Washington university school of Medicine in St. Louis. He serves as an attending emergency physician at Barnes-Jewish Hospital and a medical toxicology consultant at Barnes-Jewish Hospital and Saint Louis Children's Hospital.
Steven J FishburnKevin T. Baumgartner, MD, is a senior resident in emergency medicine and will begin a fellowship in medical toxicology in July 2019. Steven J. Fishburn, MD, MSCR, is a fellow in medical toxicology and a specialist in occupational medicine. Michael E. Mullins MD, FACEP, FAACT, is an associate professor in emergency medicine at Washington university school of Medicine in St. Louis. He serves as an attending emergency physician at Barnes-Jewish Hospital and a medical toxicology consultant at Barnes-Jewish Hospital and Saint Louis Children's Hospital.
Michael E MullinsKevin T. Baumgartner, MD, is a senior resident in emergency medicine and will begin a fellowship in medical toxicology in July 2019. Steven J. Fishburn, MD, MSCR, is a fellow in medical toxicology and a specialist in occupational medicine. Michael E. Mullins MD, FACEP, FAACT, is an associate professor in emergency medicine at Washington university school of Medicine in St. Louis. He serves as an attending emergency physician at Barnes-Jewish Hospital and a medical toxicology consultant at Barnes-Jewish Hospital and Saint Louis Children's Hospital.
Jewish Hospital · US
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
The past two decades have seen changes to the management of copperhead snakebites. We review the current use of antivenom, analgesics, and laboratory testing as well as the declining role of surgical management.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Current Management of Copperhead Snakebites in Missouri. · full record | OpenQuestion